These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9815562)

  • 1. Activity of temozolomide against human tumor colony-forming units.
    Raymond E; Izbicka E; Soda H; Gerson SL; Dugan M; Von Hoff DD
    Clin Cancer Res; 1997 Oct; 3(10):1769-74. PubMed ID: 9815562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous protection of G156A methylguanine DNA methyltransferase gene-transduced hematopoietic progenitors and sensitization of tumor cells using O6-benzylguanine and temozolomide.
    Reese JS; Davis BM; Liu L; Gerson SL
    Clin Cancer Res; 1999 Jan; 5(1):163-9. PubMed ID: 9918215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O6-benzylguanine increases the sensitivity of human primary bone marrow cells to the cytotoxic effects of temozolomide.
    Fairbairn LJ; Watson AJ; Rafferty JA; Elder RH; Margison GP
    Exp Hematol; 1995 Feb; 23(2):112-6. PubMed ID: 7828668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of SCH 66336, a tricyclic farnesyltransferase inhibitor, against human tumor colony-forming units.
    Petit T; Izbicka E; Lawrence RA; Bishop WR; Weitman S; Von Hoff DD
    Ann Oncol; 1999 Apr; 10(4):449-53. PubMed ID: 10370788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of oxaliplatin against human tumor colony-forming units.
    Raymond E; Lawrence R; Izbicka E; Faivre S; Von Hoff DD
    Clin Cancer Res; 1998 Apr; 4(4):1021-9. PubMed ID: 9563898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of single and multiple administration of an O6-benzylguanine/temozolomide combination: an evaluation in a human melanoma xenograft model.
    Wedge SR; Porteous JK; Newlands ES
    Cancer Chemother Pharmacol; 1997; 40(3):266-72. PubMed ID: 9219512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of O6-methylguanine-DNA methyltransferase in resistance of human brain tumor cell lines to the clinically relevant methylating agents temozolomide and streptozotocin.
    Bobola MS; Tseng SH; Blank A; Berger MS; Silber JR
    Clin Cancer Res; 1996 Apr; 2(4):735-41. PubMed ID: 9816224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea.
    Liu L; Markowitz S; Gerson SL
    Cancer Res; 1996 Dec; 56(23):5375-9. PubMed ID: 8968088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of temozolomide in the treatment of central nervous system tumor xenografts.
    Friedman HS; Dolan ME; Pegg AE; Marcelli S; Keir S; Catino JJ; Bigner DD; Schold SC
    Cancer Res; 1995 Jul; 55(13):2853-7. PubMed ID: 7796412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of topotecan, a new topoisomerase I inhibitor, against human tumor colony-forming units in vitro.
    Burris HA; Hanauske AR; Johnson RK; Marshall MH; Kuhn JG; Hilsenbeck SG; Von Hoff DD
    J Natl Cancer Inst; 1992 Dec; 84(23):1816-20. PubMed ID: 1331485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O6-benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair.
    Spiro TP; Gerson SL; Liu L; Majka S; Haaga J; Hoppel CL; Ingalls ST; Pluda JM; Willson JK
    Cancer Res; 1999 May; 59(10):2402-10. PubMed ID: 10344750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitization of a human ovarian cancer cell line to temozolomide by simultaneous attenuation of the Bcl-2 antiapoptotic protein and DNA repair by O6-alkylguanine-DNA alkyltransferase.
    Barvaux VA; Lorigan P; Ranson M; Gillum AM; McElhinney RS; McMurry TB; Margison GP
    Mol Cancer Ther; 2004 Oct; 3(10):1215-20. PubMed ID: 15486188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The apurinic/apyrimidinic endonuclease activity of Ape1/Ref-1 contributes to human glioma cell resistance to alkylating agents and is elevated by oxidative stress.
    Silber JR; Bobola MS; Blank A; Schoeler KD; Haroldson PD; Huynh MB; Kolstoe DD
    Clin Cancer Res; 2002 Sep; 8(9):3008-18. PubMed ID: 12231548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Plowman J; Waud WR; Koutsoukos AD; Rubinstein LV; Moore TD; Grever MR
    Cancer Res; 1994 Jul; 54(14):3793-9. PubMed ID: 8033099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules.
    Tolcher AW; Gerson SL; Denis L; Geyer C; Hammond LA; Patnaik A; Goetz AD; Schwartz G; Edwards T; Reyderman L; Statkevich P; Cutler DL; Rowinsky EK
    Br J Cancer; 2003 Apr; 88(7):1004-11. PubMed ID: 12671695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of DMP 840, a new bis-naphthalimide, on primary human tumor colony-forming units.
    Cobb PW; Degen DR; Clark GM; Chen SF; Kuhn JG; Gross JL; Kirshenbaum MR; Sun JH; Burris HA; Von Hoff DD
    J Natl Cancer Inst; 1994 Oct; 86(19):1462-5. PubMed ID: 8089865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells.
    Baer JC; Freeman AA; Newlands ES; Watson AJ; Rafferty JA; Margison GP
    Br J Cancer; 1993 Jun; 67(6):1299-302. PubMed ID: 8512814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of MGI 114 (6-hydroxymethylacylfulvene, HMAF), a semisynthetic derivative of illudin S, against adult and pediatric human tumor colony-forming units.
    Hidalgo M; Izbicka E; Eckhardt SG; MacDonald JR; Cerna C; Gomez L; Rowinsky EK; Weitman SD; Von Hoff DD
    Anticancer Drugs; 1999 Oct; 10(9):837-44. PubMed ID: 10587294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA repair enzymes and cytotoxic effects of temozolomide: comparative studies between tumor cells and normal cells of the immune system.
    Pagani E; Pepponi R; Fuggetta MP; Prete SP; Turriziani M; Bonmassar L; Lacal PM; Falcinelli S; Passarelli F; Guadagni F; Alvino E; D'Atri S
    J Chemother; 2003 Apr; 15(2):173-83. PubMed ID: 12797396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of short-term cultures derived from human malignant glioma to the anti-cancer drug temozolomide.
    Sankar A; Thomas DG; Darling JL
    Anticancer Drugs; 1999 Feb; 10(2):179-85. PubMed ID: 10211548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.